MiR-204 silencing in intraepithelial to invasive cutaneous squamous cell carcinoma progression. Issue 1 (December 2016)
- Record Type:
- Journal Article
- Title:
- MiR-204 silencing in intraepithelial to invasive cutaneous squamous cell carcinoma progression. Issue 1 (December 2016)
- Main Title:
- MiR-204 silencing in intraepithelial to invasive cutaneous squamous cell carcinoma progression
- Authors:
- Toll, Agustí
Salgado, Rocío
Espinet, Blanca
Díaz-Lagares, Angel
Hernández-Ruiz, Eugenia
Andrades, Evelyn
Sandoval, Juan
Esteller, Manel
Pujol, Ramón
Hernández-Muñoz, Inmaculada - Abstract:
- Abstract Background Cutaneous squamous cell carcinoma (cSCC) is the second most common skin cancer and frequently progresses from an actinic keratosis (AK), a sun-induced keratinocyte intraepithelial neoplasia (KIN). Epigenetic mechanisms involved in the phenomenon of progression from AK to cSCC remain to be elicited. Methods Expression of microRNAs in sun-exposed skin, AK and cSCC was analysed by Agilent microarrays. DNA methylation of miR-204 promoter was determined by bisulphite treatment and pyrosequencing. Identification of miR-204 targets and pathways was accomplished in HaCat cells. Immunofluorescence and immunohistochemistry were used to analyze STAT3 activation and PTPN11 expression in human biopsies. Results cSCCs display a marked downregulation of miR-204 expression when compared to AK. DNA methylation of miR-204 promoter was identified as one of the repressive mechanisms that accounts for miR-204 silencing in cSCC. In HaCaT cells miR-204 inhibits STAT3 and favours the MAPK signaling pathway, likely acting through PTPN11, a nuclear tyrosine phosphatase that is a direct miR-204 target. In non-peritumoral AK lesions, activated STAT3, as detected by pY705-STAT3 immunofluorescence, is retained in the membrane and cytoplasm compartments, whereas AK lesions adjacent to cSCCs display activated STAT3 in the nuclei. Conclusions Our data suggest that miR-204 may act as a "rheostat" that controls the signalling towards the MAPK pathway or the STAT3 pathway in the progressionAbstract Background Cutaneous squamous cell carcinoma (cSCC) is the second most common skin cancer and frequently progresses from an actinic keratosis (AK), a sun-induced keratinocyte intraepithelial neoplasia (KIN). Epigenetic mechanisms involved in the phenomenon of progression from AK to cSCC remain to be elicited. Methods Expression of microRNAs in sun-exposed skin, AK and cSCC was analysed by Agilent microarrays. DNA methylation of miR-204 promoter was determined by bisulphite treatment and pyrosequencing. Identification of miR-204 targets and pathways was accomplished in HaCat cells. Immunofluorescence and immunohistochemistry were used to analyze STAT3 activation and PTPN11 expression in human biopsies. Results cSCCs display a marked downregulation of miR-204 expression when compared to AK. DNA methylation of miR-204 promoter was identified as one of the repressive mechanisms that accounts for miR-204 silencing in cSCC. In HaCaT cells miR-204 inhibits STAT3 and favours the MAPK signaling pathway, likely acting through PTPN11, a nuclear tyrosine phosphatase that is a direct miR-204 target. In non-peritumoral AK lesions, activated STAT3, as detected by pY705-STAT3 immunofluorescence, is retained in the membrane and cytoplasm compartments, whereas AK lesions adjacent to cSCCs display activated STAT3 in the nuclei. Conclusions Our data suggest that miR-204 may act as a "rheostat" that controls the signalling towards the MAPK pathway or the STAT3 pathway in the progression from AK to cSCC. … (more)
- Is Part Of:
- Molecular cancer. Volume 15:Issue 1(2016)
- Journal:
- Molecular cancer
- Issue:
- Volume 15:Issue 1(2016)
- Issue Display:
- Volume 15, Issue 1 (2016)
- Year:
- 2016
- Volume:
- 15
- Issue:
- 1
- Issue Sort Value:
- 2016-0015-0001-0000
- Page Start:
- 1
- Page End:
- 15
- Publication Date:
- 2016-12
- Subjects:
- miR-204 -- Cutaneous squamous cell carcinoma -- Actinic keratosis -- Sun-induced keratinocyte intraepithelial neoplasia -- DNA methylation -- MAPK -- STAT3
Cancer -- Molecular aspects -- Periodicals
616.994 - Journal URLs:
- http://molecular-cancer.biomedcentral.com/ ↗
http://pubmedcentral.gov/tocrender.fcgi?journal=117 ↗
http://www.molecular-cancer.com/start.asp ↗
http://link.springer.com/ ↗ - DOI:
- 10.1186/s12943-016-0537-z ↗
- Languages:
- English
- ISSNs:
- 1476-4598
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 10000.xml